Decera Clinical Education Neuroscience Podcast · Decera Clinical Education

What’s New in the Treatment of Rett Syndrome?

·34 min·5 clips

Nicola Hansen frames the discussion as an update to last year's Rett Syndrome Today and Tomorrow series. She introduces David Lieberman and Eric Marsh. The focus stays on treatment, but the conversation keeps circling back to the day to day problems that matter to families and clinicians. Communication comes up first. Many individuals with Rett syndrome are nonverbal. Some have minimally verbal skills. Some use eye-gaze communication devices. Even then, expression can stay limited. Hand function is another major concern. Ambulation is part of the picture too. The speakers note that these issues are among the top complaints families raise. They also point out that many patients are already on multiple medications. Each problem tends to bring its own treatment attempts, which leaves a complicated medication landscape. Some problems have more options than others. Other concerns still have poor direct treatments. A recently published paper on the symptoms families find most bothersome is referenced in the discussion. That work helps define the unmet needs the field is still trying to address. The guests then turn to a drug that has been studied for Rett syndrome for a number of years. The field is described as working to improve daily life for people with Rett syndrome. The episode is part of the 2024 Unlocking Hope program, created in partnership with the International Rett Syndrome Foundation and supported by an educational grant from Acadia Pharmaceuticals. The broader program includes clinical thought commentaries, medical minute presentations with downloadable slide sets, and an upcoming interactive case challenge. It also includes perspectives from experts in pediatric neurology and complex care, along with parent caregivers. The show notes point listeners to those additional resources.

As heard by us

A clinical update on Rett syndrome treatment that centers family concerns and ongoing unmet need.

This episode gives a clear update on what is changing in Rett syndrome treatment, with family concerns kept front and center. Communication comes first, then hand function and ambulation, and seizures are part of the wider symptom burden.

Read the full review in PlayNext →

Why you'd press play

If you want a practical update on what's new in Rett treatment, this is the briefing.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Decera Clinical Education Neuroscience Podcast